Prospective analysis shows improved monitoring of hemoglobin in older adults may reduce mild cognitive impairment risk.
Baseline hemoglobin levels above 130 g/L were associated with reduced odds of MCI over three years. While this study does not establish causality, it suggests further investigations in monitoring and managing hemoglobin levels, even in generally healthy older adults. TRIAL REGISTRATION PAGE: https://clinicaltrials.gov/study/NCT01745263 TRIAL REGISTRATION ID: NCT01745263.
No takes yet. Share an insight, caveat, or question.
Wieczorek et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: